CN Patent

CN101822822A — 一种普兰林肽的药物组合物及其制备方法

Assigned to Beijing Dezhong Wanquan Medicines Technological Development Co Ltd · Expires 2010-09-08 · 16y expired

What this patent protects

本发明公开了一种含有普兰林肽的药物组合物，此药物组合物含有普兰林肽、pH调节剂及其它药学上可接受的载体，用于成人糖尿病患者控制血糖。

USPTO Abstract

本发明公开了一种含有普兰林肽的药物组合物，此药物组合物含有普兰林肽、pH调节剂及其它药学上可接受的载体，用于成人糖尿病患者控制血糖。

Drugs covered by this patent

Patent Metadata

Patent number
CN101822822A
Jurisdiction
CN
Classification
—
Expires
2010-09-08
Drug substance claim
No
Drug product claim
No
Assignee
Beijing Dezhong Wanquan Medicines Technological Development Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.